Manuel Vangelisti

Title: The Innovative Contributions of Manuel Vangelisti

Introduction

Manuel Vangelisti is a notable inventor based in Lyons, France. He has made significant contributions to the field of virology, particularly in the development of vaccines. With a total of three patents to his name, Vangelisti's work has the potential to impact public health positively.

Latest Patents

Vangelisti's latest patents include a live-attenuated yellow fever virus strain adapted to grow on Vero cells. This invention relates to a strain derived from a parent yellow fever virus 17D substrain that is not adapted to grow on Vero cells. The live-attenuated yellow fever virus strain is designed to be less neurovirulent than the parent strain, which is crucial for vaccine safety and efficacy.

Career Highlights

Throughout his career, Vangelisti has worked with prominent companies in the pharmaceutical and agricultural sectors. Notably, he has been associated with Sanofi Pasteur Inc. and Aventis Cropscience S.A. His experience in these organizations has contributed to his expertise in vaccine development and innovation.

Collaborations

Vangelisti has collaborated with several professionals in his field, including Nathalie Mantel and Yves Girerd-Chambaz. These collaborations have likely enhanced his research and development efforts, leading to his successful patent applications.

Conclusion

Manuel Vangelisti's contributions to vaccine development and his innovative patents highlight his importance in the field of virology. His work continues to pave the way for advancements in public health and safety.